Dostarlimab (Anti-PDCD1 / PD-1 / CD279)
Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1 programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2835 |
Sku # | A2835-1mg*5 |
Pricing | 1mg*5, $970.00 |